HPV-Related Cervical Carcinoma Clinical Trials

28 clinical trials for HPV-Related Cervical Carcinoma across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers — RECRUITING · PHASE2
• Detecting HPV DNA in Anal and Cervical Cancers — RECRUITING
• A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer — RECRUITING · PHASE1
• Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes — RECRUITING · PHASE2
• Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection — RECRUITING · NA
• Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women — RECRUITING · PHASE1
• Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples — RECRUITING · NA
• Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers — ACTIVE_NOT_RECRUITING · PHASE1
• A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial — ACTIVE_NOT_RECRUITING · NA
• HPV in Sentinel Lymph Nodes of Cervical Cancer Patients — COMPLETED · NA
• HPV Immunological Markers of Cervical Persistent Infection and Oncogenesis — OTHER
• Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer. — WITHDRAWN · PHASE2
• Self-collected Vaginal and Urine Samples in HIV-positive Women — COMPLETED
• Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial — COMPLETED · NA
• Dry Run of the ScreenUrSelf Trial — COMPLETED · NA
• STI Knowledge and HPV Vaccine Acceptance in Bamako, Mali in 2012 — COMPLETED
• This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols. — TERMINATED
• CASUS: Validation for Detection of Precursor Lesions — COMPLETED · NA
• Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) — COMPLETED · PHASE2
• Acceptability of Self-sampling for Cervical Cancer Screening — OTHER · NA
• A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years — COMPLETED · PHASE1
• An Observational Study of GP Verbal Reminders Upon Cervical Screening — COMPLETED
• FASTER-Tlalpan Study in Mexico: HPV Vaccination Impact on Cervical Cancer Screening Program — COMPLETED · PHASE4
• CASUS: Improved and Quality Assured Collection of First-void Urine — COMPLETED · NA
• Knowledge and Attitudes Towards Human Papillomavirus Infections and HPV Vaccination — COMPLETED
• Effectiveness of Targeted Educational Interventions at Increasing HPV Vaccine Acceptability and Uptake — COMPLETED · NA
• HPV Infection and Cervical Neoplasm in Women With Inflammatory Bowel Disease: a Cross-sectional Study — OTHER

Refine this search